Skip to main content

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

Abiraterone

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    Tablet 500 mg DIN : 2525380

Apo-Abiraterone

Exceptional medication

pms-Abiraterone

Exceptional medication

Sandoz Abiraterone

Exceptional medication

Dysport Therapeutic

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Ipsen Biopharmaceuticals, Canada, Inc. (Ipsen)
  • Strength and dosage form:
    • Injection Powder 300 U DIN : 2460203
    • Injection Powder 500 U DIN : 2456117

Cibinqo

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Pfizer Canada Inc. (Pfizer)
  • Strength and dosage form:
    • Tablet 100 mg DIN : 2528371
    • Tablet 200 mg DIN : 2528398
    • Tablet 50 mg DIN : 2528363

Calquence

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    AstraZeneca Canada Inc. (AZC)
  • Strength and dosage form:
    • Tablet 100 mg DIN : 2535696
    • Capsule 100 mg DIN : 2491788

Campral

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Mylan Pharmaceuticals ULC (Mylan)
  • Strength and dosage form:
    Long-Action Tablet 333 mg DIN : 2293269

Ocaliva

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Intercept Pharmaceuticals Inc. (Intercept)
  • Strength and dosage form:
    • Tablet 10 mg DIN : 2463148
    • Tablet 5 mg DIN : 2463121

Hyrimoz (syringe)

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Sandoz Canada Inc (Sandoz)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,2 mL) DIN : 2542315
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2542323
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 2542358
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 2505258
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2492164

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.